Using a hypothesis-driven integrative genetic epidemiologic approach to analysis of multi-omics data, we propose that ERCC6 may be a previously-unreported low- to moderate-risk breast cancer susceptibility gene, and that it may interact with ERCC8. Our results suggest that NER may be a good candidate for future pathway-based association studies of breast cancer. This evidence concerns the gene ERCC6 and breast cancer.